Curaleaf Holdings, Inc. (CURLF)
OTCMKTS · Delayed Price · Currency is USD
2.561
-0.169 (-6.19%)
At close: Dec 8, 2025
Curaleaf Holdings Market Cap
Curaleaf Holdings has a market cap or net worth of $2.11 billion as of December 8, 2025. Its market cap has increased by 44.34% in one year.
Market Cap
2.11B
Enterprise Value
3.12B
Revenue
1.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.56
Market Cap Chart
Since October 30, 2018, Curaleaf Holdings's market cap has decreased from 2.99B to 2.11B, a decrease of -29.32%. That is a compound annual growth rate of -4.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 1.97B | 69.22% |
| Dec 31, 2024 | 1.17B | -61.91% |
| Dec 29, 2023 | 3.06B | -0.86% |
| Dec 30, 2022 | 3.09B | -51.12% |
| Dec 31, 2021 | 6.32B | -20.27% |
| Dec 31, 2020 | 7.93B | 164.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.91M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |